Vectorious Medical Technologies Ltd is a pioneering company dedicated to revolutionizing heart failure treatment through innovative technology. They have developed the world's first in-heart microcomputer and are actively engaged in clinical studies across Europe and Israel, demonstrating significant potential to assist millions of individuals managing heart failure. As a rapidly growing organization, Vectorious has been recognized by the FDA's Breakthrough Device Designation program, highlighting their commitment to advancing medical solutions and improving patient outcomes.